HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - NYSE:HLN - US4055521003 - ADR
9.46 USD
+0.05 (+0.53%)
9.4525 USD
-0.01 (-0.08%)
HLN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. While HLN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLN has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year HLN was profitable.
HLN had a positive operating cash flow in the past year.
HLN had positive earnings in each of the past 5 years.
In the past 5 years HLN always reported a positive cash flow from operatings.
1.2 Ratios
HLN has a Return On Assets of 4.20%. This is amongst the best in the industry. HLN outperforms 86.98% of its industry peers.
With an excellent Return On Equity value of 8.92%, HLN belongs to the best of the industry, outperforming 86.98% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.11%, HLN belongs to the top of the industry, outperforming 83.85% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HLN is significantly below the industry average of 15.37%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
The Profit Margin of HLN (12.84%) is better than 87.50% of its industry peers.
In the last couple of years the Profit Margin of HLN has grown nicely.
The Operating Margin of HLN (21.31%) is better than 88.54% of its industry peers.
In the last couple of years the Operating Margin of HLN has grown nicely.
HLN's Gross Margin of 60.75% is fine compared to the rest of the industry. HLN outperforms 69.27% of its industry peers.
HLN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HLN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HLN has been reduced compared to 5 years ago.
Compared to 1 year ago, HLN has a worse debt to assets ratio.
2.2 Solvency
HLN has an Altman-Z score of 2.27. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLN's Altman-Z score of 2.27 is fine compared to the rest of the industry. HLN outperforms 66.15% of its industry peers.
The Debt to FCF ratio of HLN is 5.11, which is a neutral value as it means it would take HLN, 5.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HLN (5.11) is better than 82.29% of its industry peers.
HLN has a Debt/Equity ratio of 0.53. This is a neutral value indicating HLN is somewhat dependend on debt financing.
HLN has a worse Debt to Equity ratio (0.53) than 63.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.27 |
ROIC/WACC0.76
WACC8.07%
2.3 Liquidity
A Current Ratio of 0.98 indicates that HLN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, HLN is doing worse than 81.77% of the companies in the same industry.
A Quick Ratio of 0.78 indicates that HLN may have some problems paying its short term obligations.
The Quick ratio of HLN (0.78) is worse than 82.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.59% over the past year.
Measured over the past years, HLN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.56% on average per year.
Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
HLN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
HLN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.93% yearly.
HLN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.64% yearly.
EPS Next Y5.41%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
EPS Next 5Y9.93%
Revenue Next Year-1.43%
Revenue Next 2Y1.5%
Revenue Next 3Y2.53%
Revenue Next 5Y3.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.71, the valuation of HLN can be described as rather expensive.
HLN's Price/Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 80.73% of the companies in the same industry.
HLN is valuated rather cheaply when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.83, the valuation of HLN can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HLN indicates a somewhat cheap valuation: HLN is cheaper than 79.17% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, HLN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.71 | ||
| Fwd PE | 16.83 |
4.2 Price Multiples
81.25% of the companies in the same industry are more expensive than HLN, based on the Enterprise Value to EBITDA ratio.
84.90% of the companies in the same industry are more expensive than HLN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.19 | ||
| EV/EBITDA | 14.71 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
HLN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.64
PEG (5Y)1.12
EPS Next 2Y7.76%
EPS Next 3Y8.62%
5. Dividend
5.1 Amount
HLN has a Yearly Dividend Yield of 1.90%.
HLN's Dividend Yield is rather good when compared to the industry average which is at 6.99. HLN pays more dividend than 92.19% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.37, HLN is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.9% |
5.2 History
HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
HLN pays out 39.53% of its income as dividend. This is a sustainable payout ratio.
DP39.53%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
9.46
+0.05 (+0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap42.12B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts80
Price Target11.41 (20.61%)
Short Float %0.2%
Short Ratio1.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.9% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.76%
PT rev (3m)-2.12%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)0.88%
EPS NY rev (1m)0.21%
EPS NY rev (3m)-2.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.71 | ||
| Fwd PE | 16.83 | ||
| P/S | 2.86 | ||
| P/FCF | 16.19 | ||
| P/OCF | 13.95 | ||
| P/B | 1.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.71 |
EPS(TTM)0.48
EY5.07%
EPS(NY)0.56
Fwd EY5.94%
FCF(TTM)0.58
FCFY6.18%
OCF(TTM)0.68
OCFY7.17%
SpS3.31
BVpS4.76
TBVpS-2.96
PEG (NY)3.64
PEG (5Y)1.12
Graham Number7.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.27 |
F-Score6
WACC8.07%
ROIC/WACC0.76
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.41%
EPS Next 2Y7.76%
EPS Next 3Y8.62%
EPS Next 5Y9.93%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.43%
Revenue Next 2Y1.5%
Revenue Next 3Y2.53%
Revenue Next 5Y3.64%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.25%
EBIT Next 5Y7.7%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
What is the valuation status for HLN stock?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HALEON PLC-ADR (HLN) stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 19.71 and the Price/Book (PB) ratio is 1.99.
How financially healthy is HALEON PLC-ADR?
The financial health rating of HALEON PLC-ADR (HLN) is 4 / 10.